Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 24;8(8):CD011908.
doi: 10.1002/14651858.CD011908.pub2.

Interventions for the management of CMV-associated anterior segment inflammation

Arundhati Anshu  1 , Donald Tan, Soon-Phaik Chee, Jod S Mehta, Hla M Htoon
Affiliations

Interventions for the management of CMV-associated anterior segment inflammation

Arundhati Anshu et al. Cochrane Database Syst Rev. .

Abstract

Background: Cytomegalovirus (CMV) is a virus that usually affects people with reduced immunity. In recent years, this virus has been thought to cause repeated inflammation in the eye, in otherwise healthy people. This form of inflammation can cause damage to the cornea (the outer layer of the eye) or to the optic nerve by causing secondary glaucoma, or to both, leading to visual loss.

Objectives: Our primary objective was to assess the effects of drug therapies for the treatment of CMV-associated anterior segment inflammation.Our secondary objective was to determine the optimal dose and duration of treatment with respect to recurrence and adverse effects.

Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Trials Register) (2017, Issue 2), MEDLINE Ovid (1946 to 21 March 2017), Embase Ovid (1947 to 21 March 2017), the ISRCTN registry (www.isrctn.com/editAdvancedSearch); searched 21 March 2017, ClinicalTrials.gov (www.clinicaltrials.gov); searched 21 March 2017, and the WHO International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en); searched 21 March 2017. We did not use any date or language restrictions in the electronic searches for trials. Two review authors independently reviewed the titles and abstracts.

Selection criteria: We searched for randomised controlled trials (RCTs) on the management of CMV-associated anterior segment inflammation.

Data collection and analysis: We planned to have two review authors independently extract data from reports of included studies and analyse data based on methods expected by Cochrane.

Main results: We did not identify any RCTs that met our inclusion criteria.

Authors' conclusions: There is currently no good-quality evidence on the management of CMV-associated anterior segment inflammation. Ideally, a well-designed RCT is needed to evaluate the effectiveness of different anti-CMV medications as well as the optimal dose and duration.

PubMed Disclaimer

Conflict of interest statement

JM: none known AA: none known HMT: none known DT: none known CSP: none known

Figures

1
1
Study flow diagram.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD011908

Similar articles

See all similar articles

Cited by

References

Additional references

Ang 2013
    1. Ang M, Sng CC, Chee SP, Tan DT, Mehta JS. Outcomes of corneal transplantation for irreversible corneal decompensation secondary to corneal endotheliitis in Asian eyes. American Journal of Ophthalmology 2013;156(2):260‐6. - PubMed
Anshu 2009
    1. Anshu A, Chee SP, Mehta J, Tan DT. CMV endotheliitis in Descemet's stripping endothelial keratoplasty. Ophthalmology 2009;116(4):624‐30. - PubMed
Chee 2007
    1. Chee SP, Bacsal K, Jap A, Se‐Thoe SY, Cheng CL, Tan BH. Corneal endotheliitis associated with evidence of cytomegalovirus infection. Ophthalmology 2007;114(4):798‐803. - PubMed
Chee 2008
    1. Chee SP, Bacsal K, Jap A, Se‐Thoe SY, Cheng CL, Tan BH. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. American Journal of Ophthalmology 2008;145(5):834‐40. - PubMed
Chee 2012
    1. Chee SP, Jap A. Treatment outcome and risk factors for visual loss in cytomegalovirus endotheliitis. Graefe's Archive for Clinical and Experimental Ophthalmology 2012;250(3):383‐9. - PubMed
De Schryver 2006
    1. Schryver I, Rozenberg F, Cassoux N, Michelson S, Kestelyn P, Lehoang P, et al. Diagnosis and treatment of cytomegalovirus iridocyclitis without retinal necrosis. British Journal of Ophthalmology 2006;90(7):852‐5. - PMC - PubMed
Deeks 2011
    1. Deeks JJ, Higgins JP, Altman DG, editor(s). Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Glanville 2006
    1. Glanville JM, Lefebvre C, Miles JN, Camosso‐Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130‐6. - PMC - PubMed
GRADEpro 2014 [Computer program]
    1. GRADE Working Group, McMaster University. GRADEpro GDT. Version accessed 30 March 2017. Hamilton (ON): GRADE Working Group, McMaster University, 2014.
Higgins 2011a
    1. Higgins JP, Altman DG, Sterne JAC, editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Higgins 2011b
    1. Higgins JP, Deeks JJ, editor(s). Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Higgins 2011c
    1. Higgins JP, Deeks JJ, Altman DG, editor(s). Chapter 16: Special topics in statistics. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Jap 2011
    1. Jap A, Chee SP. Viral anterior uveitis. Current Opinion in Ophthalmology 2011;22(6):483‐8. - PubMed
Kobayashi 2012
    1. Kobayashi A, Yokogawa H, Higashide T, Nitta K, Sugiyama K. Clinical significance of owl eye morphologic features by in vivo laser confocal microscopy in patients with cytomegalovirus corneal endotheliitis. American Journal of Ophthalmology 2012;153(3):445‐53. - PubMed
Koizumi 2006
    1. Koizumi N, Yamasaki K, Kawasaki S, Sotozono C, Inatomi T, Mochida C, et al. Cytomegalovirus in aqueous humor from an eye with corneal endotheliitis. American Journal of Ophthalmology 2006;141(3):564‐5. - PubMed
Koizumi 2007
    1. Koizumi N, Suzuki T, Uno T, Chihara H, Shiraishi A, Hara Y, et al. Cytomegalovirus as an etiologic factor in corneal endotheliitis. Ophthalmology 2008;115(2):292‐7. - PubMed
Koizumi 2014
    1. Koizumi N, Inatomi T, Suzuki T, Shiraishi A, Ohashi Y, Kandori M, et al. Clinical features and management of cytomegalovirus corneal endotheliitis: analysis of 106 cases from the Japan corneal endotheliitis study. British Journal of Ophthalmology 2015;99(1):54‐8. - PMC - PubMed
Markomichelakis 2002
    1. Markomichelakis NN, Canakis C, Zafirakis P, Marakis T, Mallias I, Theodossiadis G. Cytomegalovirus as a cause for anterior uveitis with sectorial iris atrophy. Ophthalmology 2002;109(5):879‐88. - PubMed
Mietz 2000
    1. Mietz H, Aisenbrey S, Ulrich Bartz‐Schmidt K, Bamborschke S, Krieglstein GK. Ganciclovir for the treatment of anterior uveitis. Graefe's Archive for Clinical and Experimental Ophthalmology 2000;238(11):905‐9. - PubMed
Shiraishi 2007
    1. Shiraishi A, Hara Y, Takahashi M, Oka N, Yamaguchi M, Suzuki T, et al. Demonstration of "owl's eye" morphology by confocal microscopy in a patient with presumed cytomegalovirus corneal endotheliitis. American Journal of Ophthalmology 2007;143(4):715‐7. - PubMed
Sonoyama 2010
    1. Sonoyama H, Araki‐Sasaki K, Osakabe Y, Nakamura M, Amano S, Koizumi N, et al. Detection of cytomegalovirus DNA from cytomegalovirus corneal endotheliitis after penetrating keratoplasty. Cornea 2010;29(6):683‐5. - PubMed
Sterne 2011
    1. Sterne JAC, Egger M, Moher D, editor(s). Chapter 10: Addressing reporting biases. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Stewart 2011
    1. Stewart LA, Tierney JF, Clarke M. Chapter 18: Reviews of individual patient data. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Suzuki 2007
    1. Suzuki T, Hara Y, Uno T, Ohashi Y. DNA of CMV detected by PCR in aqueous of patient with corneal endothelialitis after penetrating keratoplasty. Cornea 2007;26(3):370‐2. - PubMed
Van Boxtel 2007
    1. Boxtel LA, Lelij A, Meer J, Los LI. Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology 2007;114(7):1358‐62. - PubMed

References to other published versions of this review

Anshu 2015
    1. Anshu A, Tan D, Chee SP, Mehta JS, Htoon HM. Interventions for the management of CMV‐associated anterior segment inflammation. Cochrane Database of Systematic Reviews 2015, Issue 10. [DOI: 10.1002/14651858.CD011908] - DOI - PMC - PubMed

Publication types

MeSH terms

Substances